rxstat › Classes › Anxiolytics

Anxiolytics: shortage status in Canada

6 of the 9 anxiolytics rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Chlordiazepoxide Widespread shortage 2 of 3 reported products affected Oxazepam (Oxpam) Widespread shortage 6 of 10 reported products affected Alprazolam (Xanax) Partial shortage 4 of 20 reported products affected Buspirone Partial shortage 2 of 8 reported products affected Diazepam (Diastat) Partial shortage 5 of 18 reported products affected · est. return Oct 23, 2026 Hydroxyzine (Atarax) Partial shortage 2 of 8 reported products affected Lorazepam (Ativan) Shortage anticipated 0 of 28 reported products affected Bromazepam (Lectopam) No current shortage Clobazam (Frisium) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.